Zacks Research Has Bullish Forecast for Amarin Q2 Earnings
Amarin Co. plc (NASDAQ:AMRN – Free Report) – Investment analysts at Zacks Research raised their Q2 2025 earnings estimates for Amarin in a research report issued on Tuesday, June 3rd. Zacks Research analyst R. Department now expects that the biopharmaceutical company will earn ($0.60) per share for the quarter, up from their prior forecast of […]
